Cover Image

Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI‐Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk‐Stratification Scoring System

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Toshifumi Takahashi, Masakazu Nakashima, Kouhei Maruno, Tatsuya Hazama, Yuya Yamada, Kazuro Kikkawa, Shigeaki Umeoka, Masahiro Tamaki, Noriyuki Ito
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	The Prostate
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of Second‐Line Treatment for Castration‐Resistant Prostate Cancer following the Administration of Upfront Androgen Receptor Signaling Inhibitors
by: Kazuro Kikkawa, et al.
Published: (2024)

Total en bloc spondylectomy in testicular immature teratoma: Long‐term survival amidst vertebral metastasis escalated by growing teratoma syndrome
by: Masahiro Tamaki, et al.
Published: (2024)

A case of successful treatment of Fournier's gangrene through conservative management and elective debridement
by: Toshifumi Takahashi, et al.
Published: (2024)

The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
by: Trevor C. Hunt, et al.
Published: (2025)

Current Status of Prostate Biopsy in Africa: Are We Ready for a Targeted Biopsy?
by: Ziba Ouima Justin Dieudonne, et al.
Published: (2025)

Individualized Precision Prostate Biopsy Strategy for Patients With PI‐RADS Score 2: A Retrospective Multicenter Study
by: Zhiyao Xu, et al.
Published: (2025)

Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
by: Yuto Ono, et al.
Published: (2025)

Challenging the Evolving Nomenclature of Ultrasound‐Guided Transperineal Prostate Biopsy: A Call for Standardization
by: Pedro Ivo C. Ravizzini, et al.
Published: (2026)

Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3–5 Lesions
by: Takanori Tokunaga, et al.
Published: (2025)

Is Saturation Biopsy Still a Viable Alternative to Fusion Biopsy in the Era of Multiparametric MRI? A Comparative Analysis in Patients With Prior Negative Biopsy
by: Arda Taşkın Taşkıran, et al.
Published: (2026)

Reply – Letter to the Editor: Bimodal Imaging at MRI Fusion Prostate Biopsy Will Gain Further Importance in the Future
by: Fabian Falkenbach, et al.
Published: (2025)

Reliability of Negative Prostate MRI for Biopsy Decision‐Making in the Male Han Chinese Population
by: Fangming Wang, et al.
Published: (2026)

Letter to the Editor Regarding “Challenging the Evolving Nomenclature of Ultrasound‐Guided Transperineal Prostate Biopsy: A Call for Standardization”
by: Eriz Özden, et al.
Published: (2026)

Long‐Term Oncological Outcomes of Robot‐Assisted Radical Prostatectomy for Clinically Localized Grade Groups 4 and 5 Prostate Cancers Diagnosed on Prostate Biopsy
by: Victor Sandoval, et al.
Published: (2025)

Biopsy‐Free Radical Prostatectomy: An Innovative Investigational Approach
by: Changming Wang, et al.
Published: (2025)

Spatial Distribution of Prostate Cancer Missed by MRI‐Targeted Biopsy, Effect of a Perilesional Template, and Restaging in a Radical Prostatectomy Cohort
by: Ruth Himmelsbach, et al.
Published: (2026)

The Effects of the Blood‐Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies
by: Hikari Miura, et al.
Published: (2025)

Comments on the Study “Adapting the Bellmunt Risk Score for Prognostic Stratification in Metastatic Castration‐Sensitive Prostate Cancer”
by: Xian Wen
Published: (2026)

Utility of the PROSTest, a Novel Blood‐Based Molecular Assay, Versus PSA for Prostate Cancer Stratification and Detection of Disease
by: Mark Kidd, et al.
Published: (2025)

Development and Validation of a Nomogram for Predicting Pathological Upgrading in Men With Biopsy Gleason 3 + 3 Prostate Cancer Undergoing Radical Prostatectomy: A Population‐Based Study
by: Han Li, et al.
Published: (2026)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
by: Elizabeth Robinson, et al.
Published: (2025)

Beyond Baseline: Serial PSA Measurements and Risk Stratification for Prostate Cancer
by: Anwar E. Ahmed, et al.
Published: (2025)

Automatic MRI‐TRUS Fusion Technique for Transperineal Biopsy Guidance: From Preoperative Planning to Intraoperative Navigation
by: Lu Tang, et al.
Published: (2024)

PSA Density and Lesion Volume: Key Factors in Avoiding Unnecessary Biopsies for PI‐RADS 3 Lesions
by: Ali Ayranci, et al.
Published: (2024)

Efficacy of Serenoa repens Extract Combined With Alfuzosin Versus Alfuzosin Alone in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Multicenter Randomized Study
by: Giulio Bevilacqua, et al.
Published: (2025)

Correction to “[Efficacy of Serenoa repens Extract Combined With Alfuzosin Versus Alfuzosin Alone in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Multicenter Randomized Study ( The Prostate , 2025). https://doi.org/10.1002/pros.70071]”
Published: (2026)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
by: Cameron J. Britton, et al.
Published: (2025)

Prostatic Surgery With Preservation of the Supramonticular Tissue Versus Standard Surgery for Benign Prostatic Hyperplasia: A Systematic Review
by: Giuston Mendoza‐Chuctaya, et al.
Published: (2025)

Surveillance Versus Treatment for Favorable Intermediate‐Risk Prostate Cancer and Mortality‐Risk
by: Mutlay Sayan, et al.
Published: (2026)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
by: Tatsuya Shimomura, et al.
Published: (2026)

Clinicopathological Significance of Extranodal Adipose Tissue Invasion in Metastatic Lymph Nodes in Patients With Prostate Cancer
by: Hirotaka Nagasaka, et al.
Published: (2024)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
by: Haotian Chen, et al.
Published: (2025)

Refining the CHAARTED Classification: Clinical Utility of a Novel Integrated Risk Stratification Model Incorporating Gleason Grade and Biochemical Markers in Japanese Patients With Metastatic Hormone‐Sensitive Prostate Cancer
by: Takanori Tokunaga, et al.
Published: (2025)

Preliminary Evidence on Safety and Clinical Efficacy of Luteolin for Patients With Prostate Cancer Under Active Surveillance
by: Taku Naiki, et al.
Published: (2025)

Comparison of Prognosis and Health‐Related Quality of Life Between Robot‐Assisted Radical Prostatectomy Versus High‐Dose‐Rate Brachytherapy Combined With External Beam Radiation Therapy and Hormone Therapy for High‐Risk Prostate Cancer
by: Yuya Iwahashi, et al.
Published: (2024)

A Two‐Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone‐Sensitive Prostate Cancer
by: Koichiro Kurokawa, et al.
Published: (2026)

The Clinical Significance of Gallium‐68 PSMA‐11 PET‐Derived SUVmax in the Management of Metastatic Hormone‐Sensitive Prostate Cancer
by: Cevat İlteriş Kıkılı, et al.
Published: (2026)

Significant Effect of Carbon‐Ion Radiation Therapy Combined With Androgen Deprivation on Biochemical Recurrence Rates in High‐Risk Prostate Cancer Patients: A Two‐Center Controlled Trial Compare With X‐Ray External Beam Radiation Therapy
by: Xue Zhao, et al.
Published: (2024)

Life Expectancy in High‐Grade Incidental Prostate Cancer Patients Versus Population‐Based Controls According to Treatment Type
by: Francesco Di Bello, et al.
Published: (2024)

Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients
by: Cem Onal, et al.
Published: (2024)